Central administration of methamphetamine synergizes with metabolic inhibition to deplete striatal monoamines

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 3, 2000, Pages 853-860

  Burrows, Kristan B ^a   Nixdorf, Wendy L ^a   Yamamoto, Bryan K ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; MALONIC ACID; METHAMPHETAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; BRAIN INJURY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; ENERGY METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE;

ANIMALS; BODY TEMPERATURE; CORPUS STRIATUM; DOPAMINE; DRUG SYNERGISM; ENERGY METABOLISM; GLUTAMIC ACID; MALE; MALONATES; METHAMPHETAMINE; MITOCHONDRIA; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

EID: 0034009082     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Abekawa T, Ohmori T and Koyama T (1994) Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens. Brain Res 643:276-281.
2. Albers D and Sonsalla P (1995) Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: Pharmacological profile of protective and non-protective agents. J Pharmacol Exp Ther 275:1104-1114.
3. Albers D, Zeevalk G and Sonsalla P (1996) Damage to dopaminergic nerve terminals in mice by combined treatment on intrastriatal malonate with systemic methamphetamine or MPTP. Brain Res 718:217-220.
4. Beal M, Brouillet E, Jenkins B, Henshaw R, Rosen B and Hyman B (1993) Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J Neurochem 61:1147-1150.
5. Beal M, Henshaw D, Jenkins B, Rosen B and Schulz J (1994) Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Ann Neurol 36:882-888.
6. Berger U, Molliver M and Grzanna R (1990) Unlike systemic administration of p-chloroamphetamine, direct intracerebral injection does not produce degeneration of 5-HT axons. Exp Neurol 109:257-268.
7. Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Slikker W Jr and Holson RR (1994) Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 268:1571-1580.
8. Burrows KB and Meshul CK (1999) High-dose methamphetamine treatment alters presynaptic GABA and glutamate immunoreactivity. Neuroscience 90:833-850.
9. Chan P, Di Monte DA, Luo JJ, DeLanney LE, Irwin I and Langston JW (1994) Rapid ATP loss caused by methamphetamine in the mouse striatum: Relationship between energy impairment and dopaminergic neurotoxicity. J Neurochem 62:2484-2487.
10. Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S and Schapira AH (1994) Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 345:50-54.
11. DiMauro S (1993) Mitochondrial involvement in Parkinson's disease: The controversy continues. Neurology 43:2170.
12. Donzanti BA and Yamamoto BK (1988) A rapid and simple HPLC microassay for biogenic amines in discrete brain regions. Pharmacol Biochem Behav 30:795-799.
13. Giovanni A, Liang LP, Hastings TG and Zigmond MJ (1995) Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: Impact of methamphetamine. J Neurochem 64:1819-1825.
14. Graham DG, Tiffany SM, Bell WB and Gutknecht WF (1978) Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxy dopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol 14:644-653.
15. LaVoie M and Hastings T (1999) Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: Evidence against a role for extracellular dopamine. J Neurosci 19:1484-1491.
16. Lizasoain I, Moro MA, Knowles RG, Darley-Usmar V and Moncada S (1996) Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem J 314:877-880.
17. Madl JE and Allen DL (1995) Hyperthermia depletes adenosine triphosphate and decreases glutamate uptake in rat hippocampal slices. Neuroscience 69:395-405.
18. Marey-Semper I, Gelman M and Levi-Strauss M (1993) The high sensitivity to rotenone of striatal dopamine uptake suggests the existence of a constitutive metabolic deficiency in dopaminergic neurons from the substantia nigra. Euro J Neurosci 5:1029-1034.
19. McLaughlin BA, Nelson D, Erecinska M and Chesselet MF (1998) Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor. J Neurochem 70:2406-2415.
20. Messam C, Greene J, Greenamyre J and Robinson M (1995) Intrastriatal injections of the succinate dehydrogenase inhibitor, malonate, cause a rise in extracellular amino acids that is blocked by MK-801. Brain Res 684:221-224.
21. O'Dell SJ, Weihmuller FB and Marshall JF (1991) Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res 564:256-260.
22. O'Dell SJ, Weihmuller FB, McPherson RJ and Marshall JF (1994) Excitotoxic striatal lesions protect against subsequent methamphetamine-induced dopamine depletions. J Pharmacol Exp Ther 269:1319-1325.
23. Paris J and Cunningham K (1992) Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA). Brain Res Bull 28:115-119.
24. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego,.
25. Ricaurte GA, Schuster CR and Seiden LS (1980) Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in rat brain. Brain Res 193:153-163.
26. Seiden LS, Fishman MW and Schuster CR (1975)/76) Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend 1:215-219.
27. Sonsalla PK, Gibb JW and Hanson GR (1986) Nigrostriatal dopamine actions on the D2 receptors mediate methamphetamine effects on the striatonigral substance P system. Neuropharmacology 25:1221-1230.
28. Sonsalla PK, Nicklas WJ and Heikkila RE (1989) Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science (Wash DC) 243:398-400.
29. Sonsalla PK, Riordan DE and Heikkila RE (1991) Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J Pharmacol Exp Ther 256:506-512.
30. Stephans SE, Whittingham TS, Douglas AJ, Lust WD and Yamamoto BK (1998) Substrates of energy metabolism attenuate methamphetamine-induced neurotoxicity in striatum. J Neurochem 71:613-621.
31. Stephans SE and Yamamoto BK (1994) Methamphetamine-induced neurotoxicity: Roles for glutamate and dopamine efflux. Synapse 17:203-209.
32. Suehiro E, Fujisawa H, Ito H, Ishikawa T and Maekawa T (1999) Brain temperature modifies glutamate neurotoxicity in vivo. J Neurotrauma 16:285-297.
33. Wagner GC, Lucot JB, Schuster CR and Seiden LS (1983) Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes. Brain Res 270:285-288.
34. Westerink BHC, Damsma G and de Vries JB (1989) Effect of ouabain applied by intrastriatal microdialysis on the in vivo release of dopamine, acetylcholine, and amino acids in the brain of conscious rats. J Neurochem 52:705-712.
35. Yamamoto BK and Davy S (1992) Dopaminergic modulation of glutamate release in striatum as measured by microdialysis. J Neurochem 58:1736-1742.
36. Yamamoto BK and Pehek EA (1990) A neurochemical heterogeneity of the rat striatum as measured by in vivo electrochemistry and microdialysis. Brain Res 506:236-242.
37. Yamamoto BK and Zhu W (1997) Methamphetamine, free radicals, and the production of oxidative stress. Soc Neurosci Abstr 23:2141.
38. Zeevalk G, Manzino L, Hoppe J and Sonsalla P (1997) In vivo vulnerability of dopamine neurons to inhibition of energy metabolism. Eur J Pharmacol 320;111-119.
39. Zeevalk GD and Nicklas WJ (1991) Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition. J Pharmacol Exp Ther 257:870-878.